GLP-1 drugs are reshaping the weight management landscape, but their rise has also triggered a wave of imitators making questionable claims. However, a new opportunity is emerging: the post-GLP-1 window, a category focused on helping consumers maintain progress after discontinuing these drugs. This is where GlucoVantage® fits naturally, offering support for healthy blood sugar balance and appetite control in a more sustainable long-term strategy. To learn more, download the attached deck.
